TEM: Tempus AI Inc Net earnings per share (EPS TTM)

Symbol and logo of brand Tempus AI Inc (TEM)

Tempus AI, Inc (TEM) demonstrates high stability, as oncology diagnostic costs are minimally affected by economic crises. The company is creating a unique precision medicine environment where every new profile enhances the platform's value. This 12-month EPS chart illustrates an aggressive data market capture strategy, and -1.06 shows the current earnings per share metric.

TEM (Tempus AI) Net earnings per share for the last four quarters history from 06/15/2024 to 11/11/2026

Metric breakdowns and analytics for Tempus AI Inc (TEM)

- share price and expert price forecast:
Stock Quotes Tempus AI|TEM - Fair Value Consensus
- market capitalization information:
Market Capitalization Tempus AI|TEM - Enterprise Value
- business book valuation details:
Book Value per Share Tempus|TEM - Book Valuation of Business|Market Cap to Net Assets Ratio tempus.com|TEM - Aggregate Asset Value
- debt level and financial liquidity data:
Total Debt to Capital Tempus AI, Inc|TEM - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Tempus Labs|TEM - Company Aggregate Debt|Debts to Book Capitalization Tempus AI|TEM - Company Long-Term Liabilities|Company Current Liabilities Tempus|Quick Ratio tempus.com
- net income and valuation multiples indicators:
TEM - Company Net Income|Expected Profit Tempus AI, Inc|TEM - Price to Earnings Ratio|Forward P/E Multiple Tempus|TEM - Growth-Adjusted P/E Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tempus AI|TEM - Operating profit before amortization|Net earnings per share (EPS TTM) Tempus|TEM - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months tempus.com|TEM - Net earnings per one share growth for the current year|Earnings growth forecast for next year Tempus AI, Inc
Fundamental valuation:tempus.com (TEM)
Manufactured products of Tempus Labs

For Tempus AI, Inc (TEM), a precision medicine pioneer with a unique genomic database, EPS TTM reflects the actual earnings per share by dividing the total annual net income by the total number of outstanding securities. By analyzing the rolling 12-month EPS value, an investor assesses the monetization efficiency of AI solutions in oncology and determines the business's resilience to market volatility.

Competitor analysis

QGEN: Net earnings per share for the last 12 months|Earnings per share for the trailing year IONS (ionispharma.com)|RGEN: Net earnings per share (EPS TTM)|Avidity Biosciences Inc (RNA) - Net earnings per share (EPS TTM)|CRSP (CRISPR Therapeutics Corp) - Net earnings per share (EPS TTM)|GeneDx Corp (WGS) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months RARE (Ultragenyx Pharmaceutical)|BEAM (beamtx.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) SRPT (Sarepta)|Net earnings per share for the last four quarters Twist Bioscience Inc (TWST)|TXG - Earnings per share for the last twelve months|NTLA (Intellia Corp) - Earnings per share for the last 12 months|STOK: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months biolifesolutions.com|Net earnings per share for the last 12 months WVE|MAZE (Maze Therapeutics, Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) SION|PRME - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Taysha Gene Therapies TSHA|QURE - Net earnings per share for the last 12 months|MeiraGTx - Net earnings per share (EPS TTM)|RGNX (REGENXBIO Inc) - Earnings per share for the last 12 months|Solid Bio (SLDB) - Earnings per share for the last twelve months|Earnings per share for the last 12 months OCGN|PACB (Pacific Biosciences) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) benitec.com|Net earnings per share for the last 12 months DSGN (Design Therapeutics, Inc.)|Earnings per share for the last four quarters RCKT|Net earnings per share (EPS TTM) FDMT (4D Molecular Therapeutics Inc)|Lexeo Therapeutics Inc. (LXEO) - Net earnings per one share for the last twelve months|KRRO - Earnings per share for the last twelve months|editasmedicine.com (EDIT) - Net earnings per share for the last 12 months|Silence Therapeutics plc (SLN) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months PRQR (ProQR Therapeutics)|Net earnings per share for the last 12 months CDXS|Net earnings per share (EPS TTM) Sangamo BioSciences|Earnings per share for the last twelve months Nautilus Biotechnology (NAUT)|Net earnings per share for the last four quarters metagenomi.co|Precision BioSciences, Inc. - Net earnings per share for the last 12 months|Earnings per share for the trailing year GBIO|Boundless Bio, Inc - Net earnings per share (EPS TTM)|XCUR - Net earnings per share (EPS TTM)|IMNN: Net earnings per share (EPS TTM)|PHIO - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months MBIO|RNAZ: Earnings per share for the trailing year|Net earnings per share (EPS TTM) BNGO|Net earnings per share for the last four quarters Applied DNA Corp|Earnings per share for the last twelve months bluebird bio, Inc. BLUE|IPA: Earnings per share for the last 12 months|Omega Therapeutics, Inc. - Net earnings per share (EPS TTM)|Singular Genomics Systems, Inc. (OMIC) - Net earnings per share for the last 12 months|RGLS (Regulus Therapeutics Inc) - Net earnings per share for the last 12 months|SYRS: Earnings per share for the last four quarters|TBIO (Telesis Bio, Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months traconpharma.com TCON|Earnings per share for the last twelve months Unity Biotechnology, Inc. (UBX)